Provided by Tiger Fintech (Singapore) Pte. Ltd.

ArriVent BioPharma

19.53
+0.91004.89%
Post-market: 19.530.00000.00%19:23 EDT
Volume:274.80K
Turnover:5.31M
Market Cap:792.31M
PE:-4.86
High:19.86
Open:18.74
Low:18.47
Close:18.62
52wk High:36.37
52wk Low:15.47
Shares:40.57M
Float Shares:18.29M
Volume Ratio:0.58
T/O Rate:1.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.0162
EPS(LYR):-2.5577
ROE:-50.06%
ROA:-23.41%
PB:3.17
PE(LYR):-7.64

Loading ...

Sep 09, 2024

Major Issues Report

Form 8-K - Current report
Aug 15, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 15, 2024

Major Issues Report

Form 8-K - Current report
Jul 09, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Jul 09, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Jun 05, 2024

Major Issues Report

Form 8-K - Current report
May 17, 2024

Major Issues Report

Form 8-K - Current report
May 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2024

Major Issues Report

Form 8-K - Current report
Apr 22, 2024

Major Issues Report

Form 8-K - Current report
Mar 29, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 28, 2024

Major Issues Report

Form 8-K - Current report
Feb 13, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 05, 2024

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
Feb 02, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jan 30, 2024

Major Issues Report

Form 8-K - Current report
Jan 24, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jan 23, 2024

Correspondence

Form CORRESP - Correspondence
Jan 23, 2024

Correspondence

Form CORRESP - Correspondence
Jan 22, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]